🇺🇸 FDA

Company profile · Sponsor

COLLEGIUM

COLLEGIUM PHARMACEUTICAL, INC

COLL · NYSE pharma STOUGHTON, MA, USA
Pipeline
24
Drugs
2
Patents
8

Quick answer

COLLEGIUM (COLL) is a pharma company. headquartered in STOUGHTON, MA, USA. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 2 drugs, and 8 patents to this profile..

Company facts

Ticker COLL
Exchange NYSE
Company type pharma
Headquarters STOUGHTON, MA, USA
SEC CIK 0001267565

Pipeline (24)

Search pipeline →

  1. A clinical study is aimed at comparing the effectiveness of two types of cell therapy in treating anal fistulas associated with Crohn's disease.

    COLLEGIUM

    Anal or recto-cutaneous or recto-vaginal Crohn-related fistula

    phase 3 other active

    1 trial

  2. ACARD 300 mg, 300 mg, tabletki, Microcrystalline cellulose, Native corn starch, Citric acid anhydrous (E330)

    COLLEGIUM

    aspirin-exacerbated respiratory disease

    phase 3 small molecule active

    1 trial

  3. De-escalation to ticagrelor 60 mg at day 30

    COLLEGIUM

    Non ST Segment Elevation Acute Coronary Syndrome

    phase 3 small molecule active

    1 trial

  4. Empagliflozin 10 MG

    COLLEGIUM

    Acute Decompensated Heart Failure

    phase 3 small molecule active

    1 trial

  5. Empagliflozin 20 mg

    COLLEGIUM

    Metabolic Syndrome

    phase 3 small molecule active

    1 trial

  6. Evolocumab

    COLLEGIUM

    Sars-CoV-2 Infection

    phase 3 small molecule completed

    1 trial

  7. HLD200 methylphenidate hydrochloride capsules

    COLLEGIUM

    Attention Deficit Hyperactivity Disorder

    phase 3 small molecule terminated

    1 trial

  8. IRINOTECAN

    COLLEGIUM

    Gastric Carcinoma

    phase 3 small molecule active

    1 trial

  9. Iodine Contrasts Effectiveness and Safety in Contrast Enhanced Mammography and breast magnetic resonance imaging.

    COLLEGIUM

    Breast cancer

    phase 3 other active

    1 trial

  10. Ivabradine Anpharm 5 mg film-coated tablets, Placebo: lactose monohydrate, microcrystalline cellulose, native corn starch, colloidal anhydrous silica, maltodextrin, magnesium stearate Capsule: Beef gelatin, Glycerol, Titanium dioxide

    COLLEGIUM

    Myocardial Injury after Noncardiac Surgery

    phase 3 small molecule active

    1 trial

  11. LEVONOR,1 mg/ml, roztwór do infuzji

    COLLEGIUM

    hypotension in non-cardiac surgery

    phase 3 small molecule active

    1 trial

  12. Methoxyflurane - Penthrox

    COLLEGIUM

    ST Elevation Myocardial Infarction

    phase 3 small molecule active

    1 trial

  13. Oxycodone DETERx

    COLLEGIUM

    Chronic Low Back Pain

    phase 3 small molecule completed

    1 trial

  14. Qarziba 4.5 mg/mL concentrate for solution for infusion

    COLLEGIUM

    Recurrent or progression of neuroblastoma or neuroblastoma or neuroblastoma refractory to first-line treatment.

    phase 3 small molecule active

    1 trial

  15. Ticagrelor 90 mg

    COLLEGIUM

    Myocardial Infarction

    phase 3 small molecule completed

    1 trial

  16. Ticagrelor 90mg

    COLLEGIUM

    STEMI

    phase 3 small molecule active

    1 trial

  17. lactose monohydrate - 100,00 mg/tablet cellulose microcrystalline - 95,60 mg/tablet Croscarmellose sodium - 2,00 mg/tablet Magnesium stearate - 2,40 mg/tablet table coating - OPADRY 20A82938 Yellow - COLORCON, Asmenol, 10 mg, tabletki powlekane

    COLLEGIUM

    Ischemia of the lower limbs in the course of obstructive artery disease

    phase 3 small molecule active

    1 trial

  18. Crushed ticagrelor followed by morphine

    COLLEGIUM

    Unstable Angina Pectoris

    approved small molecule completed

    2 trials

  19. Levosimendan

    COLLEGIUM

    Systolic Heart Failure

    approved small molecule active

    1 trial

  20. Morphine

    COLLEGIUM

    ST-segment Elevation Myocardial Infarction

    approved small molecule completed

    1 trial

  21. Pulverized ticagrelor sublingually

    COLLEGIUM

    Unstable Angina Pectoris

    approved small molecule completed

    1 trial

  22. Rifaximin

    COLLEGIUM

    ACS - Acute Coronary Syndrome

    approved small molecule active

    1 trial

  23. Rosuvastatin and Ezetimibe morning or evening administration

    COLLEGIUM

    Hypercholesterolemia

    approved small molecule completed

    1 trial

  24. Ticagrelor followed with Methoxyflurane

    COLLEGIUM

    Unstable Angina

    approved small molecule completed

    1 trial

Drugs (2)

Search drugs →

  1. oxycodone

    XTAMPZA ER

    ORAL approved

  2. tapentadol hydrochloride

    TAPENTADOL HYDROCHLORIDE

    ORAL approved

Patents (8)

Search patents →

  1. US 11191758

    Use of selective serotonin 5-HT1A receptor agonists for treating side-effects of VMAT inhibitors

    Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10668060

    Tamper-resistant pharmaceutical compositions of opioids and other drugs

    Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10646485

    Process of making stable abuse-deterrent oral formulations

    Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10525052

    Abuse-deterrent drug formulations

    Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10525053

    Abuse-deterrent pharmaceutical compositions of opioids and other drugs

    Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10188644

    Process of making stable abuse-deterrent oral formulations

    Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10004729

    Tamper-resistant pharmaceutical compositions of opioids and other drugs

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9968598

    Process of making stable abuse-deterrent oral formulations

    Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is COLLEGIUM?

COLLEGIUM (COLL) is a pharma company. headquartered in STOUGHTON, MA, USA. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 2 drugs, and 8 patents to this profile..

What pipeline programs does COLLEGIUM sponsor?

We track 24 ClinicalTrials.gov-linked programs for COLLEGIUM, including A clinical study is aimed at comparing the effectiveness of two types of cell therapy in treating anal fistulas associated with Crohn's disease. and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does COLLEGIUM company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.